Dabigatran of etexilate (paradox®) for the patients with closed diaphyseal fractures of the femur and tibia
https://doi.org/10.24884/1607-4181-2014-21-2-65-68
Abstract
The results of application of dabigatran etexilate in treatment of 56 patients aged 60 to 89 with closed diaphyseal fractures of femur and tibia undergone intramedullary osteosynthesis were studied. The patients were divided into 2 groups. The first group consisted of patients receiving standard anticoaqulant therapy. The second one included patients who used etyek-silat (pradaxa OS) in early postoperative period. The results of treatment in these groups were analysed and compared. Evidence-based significant advantage of dabigatran etexilate (pradaxaR) administration in early postoperative period was revealed.
About the Authors
A. K. Dulaev
Первый Санкт-Петербургский государственный медицинский университет имени академика И.П. Павлова; Санкт-Петербургский НИИ скорой помощи имени И.И. Джанелидзе
Russian Federation
Russian Federation
A. N. Tsed
Первый Санкт-Петербургский государственный медицинский университет имени академика И.П. Павлова; Санкт-Петербургский НИИ скорой помощи имени И.И. Джанелидзе
Russian Federation
Russian Federation
I. G. Dzhusoev
Первый Санкт-Петербургский государственный медицинский университет имени академика И.П. Павлова; Санкт-Петербургский НИИ скорой помощи имени И.И. Джанелидзе
Russian Federation
Russian Federation
References
1. Заболотских И.Б., Синьков С.В. Основы гемостазиологии. - Краснодар, 2002. - 214 с.
2. Зубаиров Д.М. Молекулярные основы свертывания крови и тромбообразования. - Казань: Фэн, 2000. - 364 с.
3. Тихилов Р.М., Стойко Ю.М., Замятин М.Н., Божкова С.А. Профилактика тромбоэмболических осложнений в травматологии и ортопедии: метод. реком. / под ред. акад. РАМН Ю.Л. Шевченко. - М., 2006. - С. 20.
4. Lindblad B., Sternby N.H., Bergqvist D. Incidence of venous thromboembolism verified by necropsy over 30 years // Br. Med. J. - 1991. - Vol. 302. - P. 709-711.
5. Nordstrom M., Lindblad B., Bergqvist D. et al. A prospective study of the incidence of deep-vein thrombosis within a defined urban population // J. Intern. Med. - 1992. - Vol. 232. -P. 155-160.
6. Turpie A.G. Oral, direct factor Xa inhibitors in development for the prevention and treatment of thromboembolic diseases // Arterioscler. Thromb. Vase Biol. - 2007. - № 27. - Р. 1238-1247.
7. Verlato F., Bruchi O., Prandoni P. The value of ultrasound screening for proximal vein thrombosis after total hip arthroplasty a prospective cohort study // Thromb. Haemost. - 2001. -Vol. 86. - P. 534-537.
Review
For citations:
Dulaev A.K., Tsed A.N., Dzhusoev I.G. Dabigatran of etexilate (paradox®) for the patients with closed diaphyseal fractures of the femur and tibia. The Scientific Notes of the Pavlov University. 2014;21(2):65-68. (In Russ.) https://doi.org/10.24884/1607-4181-2014-21-2-65-68
Views:
1051
Email this article 